Currently, Olaf Schermeier is CEO-Global Research & Development at Fresenius Medical Care AG & Co. KGaA and Chairman-Supervisory Board for Xenios AG (a subsidiary of Fresenius Medical Care AG & Co. KGaA). Dr. Schermeier is also on the board of Medos Medizintechnik AG and Member of Stifterverband für die Deutsche Wissenschaft eV, Member-Management Board at Fresenius Medical Care Management AG and Member-Administration Board at Unicyte AG. In the past Olaf Schermeier occupied the position of Manager-Strategic Product Planning at BIOTRONIK SE & Co. KG, Development Engineer at Robodent GmbH, President-Global Research & Development at Dräger Medical GmbH and Research Engineer at Charité - Universitätsmedizin Berlin. Dr. Schermeier received a doctorate from Technical University of Berlin and an undergraduate degree from the University of Hannover.

- No news -